Thursday, September 21, 2023 10:28:51 AM
maverick_1 Member Level Wednesday, 07/03/19 12:21:45 AM
Re: sentiment_stocks post# 235292
Post # of 235353
This would fit NWBO circumstances: FDA’s Real World Evidence (RWE)
Quote:
Re: maverick_1 Post# 231976
Acting FDA Commissioner Sharpless Weighs in on RWE, Drug Pricing, and Talent
Quote:
In a speech, the U.S. Food and Drug Administration (FDA)acting Commissioner Ned Sharpless said that [the agency is “open for business” in taking into consideration real-world evidence (RWE) for new cancer drugs. “The FDA is always going to want to see really well-designed beautiful trials with convincing endpoints,” Sharpless said in his talk. “If you can do a large [randomized controlled trial] with overall survival as your outcome, there is nothing better.
”https://www.biospace.com/article/bio-roundup-agenus-fda-mercy-s-frazier-and-much-more/
https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence
JPMorgan CHASE’S Jamie Dimon Gives Keynote Address
On June 5, Jamie Dimon, chairman and chief executive officer of JPMorgan Chase gave the keynote address. He also had a wide-ranging chat with Jim Greenwood, president and chief executive officer of BIO, about drug pricing and healthcare costs. “U.S. healthcare costs are now almost 20% of GDP—more than twice the amount per person compared with most developing nations. Yet our outcomes are not twice as good,” Dimon noted. He noted that most of the world’s healthcare is around 9% of GDP. And while the U.S. has some of the best healthcare, it has some of the worst outcomes[
By choice in choosing the RIGHT PATH (meaning always AHEAD/ON versus OFF the Curve) over 30 years ago:
1) I have NOT had to spend a penny on healthcare since 1985 vs what 99% EXPERIENCE.
I avoided like the plague what others have succumbed to:
Food companies: fast food;
SUGAR; FRUCTOSE over a period of time increases INFLAMMATION.... TOXIC
2)Given my background as previously posted:https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124302143d with Investment DISCIPLINE and my own DD to avoid catastrophic periods that NWBO and many other companies even an Apple have succumbed to which I anticipated here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124062573
FOR NEWBIES: Suggest one read my posts since early May 2019
AND
Especially this one:
Quote:
FALLACY of Investors: SCIENTIFICALLY focused on the TREES (science)and clear disregard for the FOREST(Investment process/discipline etc): to NOT expect DILUTION from the end of 2015 says it ALL! especially with clinical halt .
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144337217
That's why:
DIFFERENT STROKES FOR DIFFERENT FOLKS
Replies:
Thanks Mav, got an email about this today
iwasadiver on 6/7/2019 3:19:01 PM
In a speech, the U.S. Food and Drug
longfellow95 on 6/7/2019 3:49:40 PM
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM